Pharvaris director plans sale of 52,500 shares

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) director Elisabeth E. Bjork has filed a notice of proposed sale on Form 144 covering 52,500 shares of common stock. The shares are expected to be sold through Morgan Stanley Smith Barney LLC, following a stock option exercise for cash dated September 17, 2026.

Key Figures

Shares proposed for sale: 52,500 shares Aggregate market value: $1,989,408.75 Planned sale and exercise date: September 17, 2026 +2 more

5 metrics

Shares proposed for sale 52,500 shares Common stock covered by the Form 144 notice

Aggregate market value $1,989,408.75 Value of 52,500 Pharvaris N.V. common shares in the proposed Rule 144 sale

Planned sale and exercise date September 17, 2026 Date listed for the stock option exercise and proposed sale

Security type Common stock Class of Pharvaris N.V. securities to be sold

Form type Form 144 Notice of proposed sale of restricted or control securities

Key Terms

Rule 144, Form 144, stock option exercise

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"Common | 09/17/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for PHVS disclose?

It discloses that director Elisabeth E. Bjork plans to sell 52,500 shares of Pharvaris N.V. common stock under Rule 144, with the planned sale associated with a stock option exercise for cash on September 17, 2026.

How many Pharvaris (PHVS) shares are covered by Elisabeth E. Bjork’s Form 144?

The Form 144 covers a proposed sale of 52,500 shares of Pharvaris N.V. common stock, to be sold following a stock option exercise and handled through a brokerage arrangement.

What is the aggregate market value of the PHVS shares in this Form 144?

The filing states an aggregate market value of $1,989,408.75 for the 52,500 Pharvaris N.V. common shares that are the subject of the proposed Rule 144 sale.

When is the planned sale date in the Pharvaris (PHVS) Form 144?

The filing lists September 17, 2026 in connection with both the stock option exercise and the proposed sale of 52,500 common shares of Pharvaris N.V. under Rule 144.

Which broker is involved in the PHVS Form 144 transaction?

The proposed sale of 52,500 Pharvaris N.V. common shares is listed as being handled through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:45 PM Accepted by SEC EDGAR 09/17/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001810406
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	ELISABETH E. BJORK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	52500	1989408.75	70204506	09/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2026	Stock Option Exercise	Issuer			52500	09/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elisabeth Bjork
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)